Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Accenture
Cipla
Deloitte
Baxter
Harvard Business School
Dow
Fish and Richardson
Argus Health

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088750

« Back to Dashboard

NDA 088750 describes METHYCLOTHIAZIDE, which is a drug marketed by Ivax Pharms, Mylan, Mylan Pharms Inc, Par Pharm, Usl Pharma, Watson Labs, and Yaopharma Co Ltd, and is included in fifteen NDAs. It is available from one supplier. Additional details are available on the METHYCLOTHIAZIDE profile page.

The generic ingredient in METHYCLOTHIAZIDE is deserpidine; methyclothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; methyclothiazide profile page.
Summary for 088750
Tradename:METHYCLOTHIAZIDE
Applicant:Watson Labs
Ingredient:methyclothiazide
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 088750

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength2.5MG
Approval Date:Sep 6, 1984TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Fuji
Chinese Patent Office
Cantor Fitzgerald
Healthtrust
Dow
Johnson and Johnson
Citi
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.